Valvulopathies

Periprocedural and one-year mortality and perioperative outcomes from TAVI device explants across various etiologies, as recorded in the EXPANT-TAVR international registry.

This article retrospectively analyzes clinical and hemodynamic outcomes in 689 adults who underwent surgical aortic valve replacement with the Carpentier Edwards Magna Ease® bioprosthesis over a ten-year follow-up. 

This retrospective analysis spans ten years of single-center interventions, evaluating the Commando procedure in non-infectious mitral-aortic involvement cases.

A retrospective study at Mayo Clinic analyzed outcomes of mild or moderate tricuspid repair among 1,588 patients with degenerative mitral valve disease.

This retrospective analysis examines both short- and long-term outcomes (spanning thirteen years) of patients treated with Perceval® sutureless valves at a single Belgian center. 

In-depth analysis of the German multicenter DEDICATE study presents one-year outcomes in low-surgical-risk TAVI patients compared to aortic valve replacement, allowing the inclusion of patients younger than 75 years.

This single-center, observational, retrospective study evaluates early valve replacement in asymptomatic adults with severe aortic stenosis.

A multicenter Italian study presents outcomes comparing mechanical and biological prostheses in aortic valve replacement due to infective endocarditis in young patients.

Five-year results from the AVALON registry on percutaneous versus surgical treatment of aortic stenosis in low-risk patients, compared to updated evidence from key clinical trials for the same patient profile.